By Adjunct Professor Michael Leonard Friedlander

Journal articles

Israel AA; Friedlander M, 1998, 'Inorganic carbon utilization and growth abilities in the marine red macroalga Gelidiopsis sp.', ISRAEL JOURNAL OF PLANT SCIENCES, 46, pp. 117 - 124, http://dx.doi.org/10.1080/07929978.1998.10676718

Links MJ; Ribeiro JC; Jackson P; Friedlander ML; Russell PJ, 1998, 'Regulation and deregulation of G2 checkpoint proteins with cisplatin', Anticancer Research, 18, pp. 4057 - 4066

Beller E; Tattersall M; Lumley T; Levi J; Dalley D; Olver I; Page J; Abdi E; Wynne C; Friedlander M; Boadle D; Wheeler H; Margrie S; Simes RJ, 1997, 'Improved quality of life with megestrol acetate in patients with endocrine-insensitive advanced cancer: A randomised placebo-controlled trial', Annals of Oncology, 8, pp. 277 - 283, http://dx.doi.org/10.1023/A:1008291825695

Friedlander M, 1997, 'A menopausal woman with a history of breast cancer: Should she receive HRT?', Modern Medicine of Australia, 40, pp. 164 - 165

Michael M; Bishop JF; Levi JA; Bell DR; Zalcberg JR; Friedlander ML; Olver LN; Smith JG; Toner GC, 1997, 'Australian multicentre phase II trial of paclitaxel in women with metastatic breast cancer and prior chemotherapy', Medical Journal of Australia, 166, pp. 520 - 523, http://dx.doi.org/10.5694/j.1326-5377.1997.tb123243.x

Kefford R; Tucker K; Friedlander M; Kirk J, 1997, 'Cancer in the family. Guidelines for general practice.', Australian Family Physician, 26, pp. 545 - 549

Friedlander M; Tucker K, 1997, 'Hereditary ovarian cancer: Genetic basis and management issues', Cancer Forum, 21, pp. 10 - 13

Friedlander M; De Gramont A; Millward MJ; Bell D; Bugat R; Harnett P; Moreno JA; Campbell L; Rippche V; Kayitalire L, 1997, 'Activity of Gemcitablne in stage 3 or 4 ovarian cancer: Patients previously treated with cisplatin (CP)-containing regimens', European Journal of Cancer, 33, pp. S120 - S121, http://dx.doi.org/10.1016/s0959-8049(97)85054-x

Friedlander ML; Kerr JL; Hurst T; Shih A; Purdie DM; Bergman L; Chenevix-Trench G; Sanderson B; Zournazi A; Coombs T; Leary JA; Crawford E; Shelling AN; Cooke I; Ganesan TS; Searle J; Choi J; Barrett JW; Khoo SK; Ward B, 1997, 'Analysis of loss of heterozygosity and KRAS2 mutations in ovarian neoplasms: Clinicopathological correlations', Genes Chromosomes and Cancer, pp. 75 - 83

Weinberger F; Hoppe H-G; Friedlander M, 1997, 'Bacterial induction and inhibition of a fast mecrotic response in Gracilaria conferta (Rhodophyta)', Journal of Applied Phycology, 9, pp. 277 - 285, http://dx.doi.org/10.1023/a:1007990712925

Katz S; Dubinsky Z; Rothmann C; Malik Z; Friedlander M, 1997, 'Single-cell pigmentation of Porphyra linearis analyzed by Fourier transform multi-pixel spectroscopy and image analysis', JOURNAL OF PHYCOLOGY, 33, pp. 425 - 432, http://dx.doi.org/10.1111/j.0022-3646.1997.00425.x

Kerr J; Leary JA; Hurst T; Shih YC; Antalis TM; Friedlander M; Crawford E; Khoo SK; Ward B; Chenevix-Trench G, 1996, 'Allelic loss on chromosome 7q in ovarian adenocarcinomas: Two critical regions and a rearrangement of the PLANH1 locus', Oncogene, 13, pp. 1815 - 1818

Friedlander M; Levy D; Hornung H, 1996, 'The effect of cooling seawater effluents of a power plant on growth rate of cultured Gracilaria conferta (Rhodophyta)', HYDROBIOLOGIA, 332, pp. 167 - 174, http://dx.doi.org/10.1007/BF00031922

Zalcberg JR; Friedlander ML; Collopy BT; Barton M; Gray B, 1996, 'Treatment principles in advanced colorectal cancer (vol 66, pg 202, 1996)', AUSTRALIAN AND NEW ZEALAND JOURNAL OF SURGERY, 66, pp. 503 - 503, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1996UX20100021&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kavallaris M; Leary JA; Barrett JA; Friedlander ML, 1996, 'MDR1 and multidrug resistance-associated protein (MRP) gene expression in epithelial ovarian tumors', Cancer Letters, 102, pp. 7 - 16, http://dx.doi.org/10.1016/0304-3835(96)04143-2

Zalcberg JR; Friedlander ML; Collopy BT; Barton M; Gray B, 1996, 'Erratum: Treatment principles in advanced colorectal cancer (Australian and New Zealand Journal of Surgery (1996) 66 (202-205))', Australian and New Zealand Journal of Surgery, 66, pp. 503

Millward MJ; Bishop JF; Friedlander M; Levi JA; Goldstein D; Olver IN; Smith JG; Toner GC; Rischin D; Bell DR, 1996, 'Phase II trial of a 3-hour infusion of paclitaxel in previously untreated patients with advanced non-small-cell lung cancer', Journal of Clinical Oncology, 14, pp. 142 - 148, http://dx.doi.org/10.1200/JCO.1996.14.1.142

Zalcberg JR; Friedlander ML; Collopy BT; Barton M; Gray B, 1996, 'Treatment principles in advanced colorectal cancer', Australian and New Zealand Journal of Surgery, 66, pp. 202 - 205, http://dx.doi.org/10.1111/j.1445-2197.1996.tb01164.x

Friedlander M; Weintraub N; Freedman A; Sheer J; Snovsky Z; Shapiro J; Kissil GW, 1996, 'Fish as potential biocontrollers of Gracilaria (Rhodophyta) culture', Aquaculture, 145, pp. 113 - 118, http://dx.doi.org/10.1016/s0044-8486(96)01350-6

Friedlander M; Gonen Y; Kashman Y; Beer S, 1996, 'Gracilaria conferta and its epiphytes .3. Allelopathic inhibition of the red seaweed by Ulva cf lactuca', JOURNAL OF APPLIED PHYCOLOGY, 8, pp. 21 - 25, http://dx.doi.org/10.1007/BF02186217

Phillips KA; Fitzharris B; Friedlander M; McCrystal M; Olver I; Joughin J; Bishop J; Evans B; Smith J, 1995, 'Australasian multicentre phase II study of paclitaxel (Taxol) in relapsed ovarian cancer', Australian and New Zealand Journal of Medicine, 25, pp. 337 - 343, http://dx.doi.org/10.1111/j.1445-5994.1995.tb01899.x

Links M; Friedlander M, 1995, 'High-dose chemotherapy in gynaecological cancers: Does more mean better?', Current Opinion in Obstetrics and Gynecology, 7, pp. 49 - 52, http://dx.doi.org/10.1097/00001703-199507010-00010

De Souza PL; Friedlander ML, 1995, 'Humoral hypercalcemia associated with adenocarcinoma of the rectum: A case report and review of the literature', American Journal of Clinical Oncology Cancer Clinical Trials, 18, pp. 126 - 129, http://dx.doi.org/10.1097/00000421-199504000-00006

Leary JA; Kerr J; Chenevix‐Trench G; Doris CP; Hurst T; Houghton CRS; Friedlanders ML, 1995, 'Increased expression of the nme1 gene is associated with metastasis in epithelial ovarian cancer', International Journal of Cancer, 64, pp. 189 - 195, http://dx.doi.org/10.1002/ijc.2910640308

Shannon JA; Donnellan MJ; Friedlander ML; Harnett PR, 1995, 'Persisting elevation of alphafetoprotein after chemotherapy for germ cell tumour-not always due to viable malignancy?', European Journal of Cancer, 31, pp. 1722, http://dx.doi.org/10.1016/0959-8049(95)00303-Z

Zalcberg JR; Bishop JF; Millward MJ; Zimet A; Laird J; Barter C; Seward D; McKeage MJ; Friedlander ML; Toner G; Berille J; Blanc C, 1995, '1084 Interim results of a phase II trial of docetaxel in combination with cisplatin in patients with metastatic or locally advanced non-small cell lung cancer (NSCLC)', European Journal of Cancer, 31, pp. S226 - S226, http://dx.doi.org/10.1016/0959-8049(95)96330-g

ISRAEL AA; FRIEDLANDER M; NEORI A, 1995, 'BIOMASS YIELD, PHOTOSYNTHESIS AND MORPHOLOGICAL EXPRESSION OF ULVA-LACTUCA', BOTANICA MARINA, 38, pp. 297 - 302, http://dx.doi.org/10.1515/botm.1995.38.1-6.297

GONEN Y; KIMMEL E; FRIEDLANDER M, 1995, 'DIFFUSION BOUNDARY-LAYER TRANSPORT IN GRACILARIA-CONFERTA (RHODOPHYTA)', JOURNAL OF PHYCOLOGY, 31, pp. 768 - 773, http://dx.doi.org/10.1111/j.0022-3646.1995.00768.x

Links M; Friedlander M, 1995, 'High-dose chemotherapy in gynaecological cancers', Current Opinion in Obstetrics and Gynecology, 7, pp. 49 - 52, http://dx.doi.org/10.1097/00001703-199502000-00010

Van Der Velden J; Gitch G; Wain GV; Friedlander ML; Hacker NF, 1995, 'Tamoxifen in patients with advanced epithelial ovarian cancer', International Journal of Gynecological Cancer, pp. 301 - 305

Gitch G; Friedlander ML; Wain GV; Hacker NF, 1995, 'Uterine papillary serous carcinaoma: a clinical study', Cancer, pp. 2239 - 2243

FRIEDLANDER M; LEWIS C; GOLDSTEIN D, 1994, 'UNTITLED', MEDICAL JOURNAL OF AUSTRALIA, 161, pp. 638 - 638

SEGELOV E; FRIEDLANDER M, 1994, 'PROGNOSTIC FACTORS FOR WOMEN WITH OVARIAN GERM-CELL TUMORS - REPLY', JOURNAL OF CLINICAL ONCOLOGY, 12, pp. 1738 - 1738, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1994PA25700031&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Chenevix-Trench G; Kerr J; Friedlander M; Hurst T; Sanderson B; Coglan M; Ward B; Leary J; Khoo SK, 1994, 'Homozygous deletions on the short arm of chromosome 9 in ovarian adenocarcinoma cell lines and loss of heterozygosity in sporadic tumors', American Journal of Human Genetics, 55, pp. 143 - 149

Segelov E; Stuart-Harris R; Bell D; Tattersall M; Hutton-Potts J; Friedlander M, 1994, 'A phase II study of carboplatin and cisplatin in advanced ovarian cancer', European Journal of Gynaecological Oncology, 15, pp. 277 - 282

Segelov E; Campbell J; Ng M; Tattersall M; Rome R; Free K; Hacker N; Friedlander ML, 1994, 'Cisplatin-based chemotherapy for ovarian germ cell malignancies: The Australian experience', Journal of Clinical Oncology, 12, pp. 378 - 384, http://dx.doi.org/10.1200/JCO.1994.12.2.378

Quinn M; Murray J; Friedlander M; Steigrad S; Khoo S; Marsden D; Hammond I; Jobling T, 1994, 'EMACO in High Risk Gestational Trophoblast Disease ‐ The Australian Experience', Australian and New Zealand Journal of Obstetrics and Gynaecology, 34, pp. 90 - 92, http://dx.doi.org/10.1111/j.1479-828X.1994.tb01047.x

De Souza P; Friedlander M; Wilde C; Kirsten F; Ryan M, 1994, 'Hypersensitivity reactions to etoposide: A report of three cases and review of the literature', American Journal of Clinical Oncology Cancer Clinical Trials, 17, pp. 387 - 389, http://dx.doi.org/10.1097/00000421-199410000-00005

Mayordomo JI; Paz-Ares L; Diaz-Puente MT; Lianes P; Garcia-Prats MD; Cortes-Funes H; Segelov E; Friedlander M, 1994, 'Prognostic factors for women with ovarian germ cell tumors [2]', Journal of Clinical Oncology, 12, pp. 1737 - 1738, http://dx.doi.org/10.1200/JCO.1994.12.8.1737

Mackintosh JF; Friedlander M; Lewis C; Goldstein D; Herrmann RP; Kearsley JH, 1994, 'Wanted: Guidelines for 'palliative' anti-cancer drug use [3]', Medical Journal of Australia, 161, pp. 638 - 639, http://dx.doi.org/10.5694/j.1326-5377.1994.tb127659.x

GONEN Y; KIMMEL E; FRIEDLANDER M, 1994, 'ATTENUATION OF WATER VELOCITY AND INCIDENT LIGHT AS A FUNCTION OF SHAPE-PARAMETERS IN GRACILARIA', JOURNAL OF APPLIED PHYCOLOGY, 6, pp. 381 - 390, http://dx.doi.org/10.1007/BF02182154

LEVY I; FRIEDLANDER M, 1994, 'SEASONAL GROWTH-ACTIVITY OF LOCAL AND FOREIGN GRACILARIOID STRAINS IN ISRAEL', JOURNAL OF APPLIED PHYCOLOGY, 6, pp. 447 - 454, http://dx.doi.org/10.1007/BF02182397

Lewis CR; Segelov E; Goldstein D; Friedlander ML, 1993, 'Chemotherapy made easier.', Australian and New Zealand Journal of Medicine, 23, pp. 387 - 392, http://dx.doi.org/10.1111/j.1445-5994.1993.tb01440.x

Leary JA; Doris CP; Boltz EM; Houghton CRS; Kefford RF; Friedlander ML, 1993, 'Investigation of loss of heterozygosity at specific loci on chromosomes 3p, 6q, 11p, 17p and 17q in ovarian cancer 11p, 17p and 17q in ovarian cancer', International Journal of Gynecological Cancer, 3, pp. 293 - 298, http://dx.doi.org/10.1046/j.1525-1438.1993.03050293.x

FRIEDLANDER M; DAWES C; LEVY I, 1993, 'EXPOSURE OF GRACILARIA TO VARIOUS ENVIRONMENTAL-CONDITIONS .1. THE EFFECT ON GROWTH', BOTANICA MARINA, 36, pp. 283 - 288, http://dx.doi.org/10.1515/botm.1993.36.4.283

Hornung H; Kress N; Friedlander M, 1992, 'TRACE ELEMENT CONCENTRATIONS IN INTERTIDAL ALGAE COLLECTED ALONG THE MEDITERRANEAN SHORE, ISRAEL', FRESENIUS ENVIRONMENTAL BULLETIN, 1, pp. 84 - 89

Leary JA; Edwards BG; Houghton CRS; Kefford RF; Friedlander ML, 1992, 'Amplification of HER-2/neu oncogene in human ovarian cancer', International Journal of Gynecological Cancer, 2, pp. 291 - 294, http://dx.doi.org/10.1046/j.1525-1438.1992.02060291.x

Levi JA; Wheeler HR; Friedlander M; Tattersall MHN; Kefford R; Dalley D, 1992, 'Dual sequential non-cross-resistant chemotherapy for advanced stage squamous cell carcinoma of the cervix', Gynecologic Oncology, 45, pp. 329 - 333, http://dx.doi.org/10.1016/0090-8258(92)90314-9

Chenevix-Trench G; Leary J; Kerr J; Michel J; Kefford R; Hurst T; Parsons PO; Friedlander M; Khoo SK, 1992, 'Frequent loss of heterozygosity on chromosome 18 in ovarian adenocarcinoma which does not always include the DCC locus', Oncogene, 7, pp. 1059 - 1065

De Souza PL; Friedlander ML, 1992, 'Prognostic factors in ovarian cancer', Hematology Oncology Clinics of North America, 6, pp. 761 - 781, http://dx.doi.org/10.1016/s0889-8588(18)30309-5

Back to profile page